Condor Capital Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,515
Closed -$75K 357
2022
Q3
$75K Hold
7,515
0.01% 251
2022
Q2
$74K Buy
7,515
+5,295
+239% +$52.9K 0.01% 244
2022
Q1
$22K Sell
2,220
-1,000
-31% -$9.99K ﹤0.01% 325
2021
Q4
$32K Buy
+3,220
New +$32.3K ﹤0.01% 257

Other funds holding BIOSU

Condor Capital Management's BIOSU Position: Q4 2022 in Review

Condor Capital Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q4 2022, closing a stake of 7,515 shares — an estimated $75K sold.

Condor Capital Management first reported a position in BIOSU in Q4 2021 and held it in 4 quarters. The position peaked at $75K in Q3 2022. 11 funds tracked by Wall St. Rank hold BIOSU as of Q4 2022.

  • Condor Capital Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • Condor Capital Management sold 7,515 BioPlus Acquisition Corp. Unit shares in Q4 2022, an estimated $75K.
  • Condor Capital Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • Condor Capital Management's BioPlus Acquisition Corp. Unit position peaked at $75K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q4 2022.

Based on Condor Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.